Kate Bingham
InvestorManaging Partner at SV Health Investors
Writes $30K – $3M checks · typically $1.5M
About
Kate Bingham co-leads the biotech franchise at SV Health Investors, focusing on drug discovery and development companies across the UK, EU, and US, and has led many of the firm's company-creation investments. She chaired the UK Vaccine Taskforce, for which she was awarded a DBE in 2021, and holds a first class degree in Biochemistry from the University of Oxford and an MBA from Harvard Business School. She also serves on the boards of the Francis Crick Institute and ARIA.
Invests in
Biotech
Colleagues at SV Health Investors
A.J. Rossi
Partner at SV Health Investors
Aaron Sandoski
MCF Partner at SV Health Investors
Alex Badamchi-Zadeh
Vice President at SV Health Investors
Andrew Cappetta
Senior Associate at SV Health Investors
Brent Faduski
CFO, CCO and Partner at SV Health Investors
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors